GT Biopharma (GTBP) Dividend Coverage Ratio (2025)
GT Biopharma's (GTBP) quarterly Dividend Coverage Ratio came in at 52.19 in Q4 2025.
Powered by 
Analysis
GT Biopharma (GTBP) Dividend Coverage Ratio (2025) Analysis & Trends
GT Biopharma (GTBP) has reported Dividend Coverage Ratio for 1 consecutive years, with 52.19 the latest figure, recorded in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.55 Bn | 192.56 Bn | 7.24 Bn | 1.74 |
| 2 | Gilead Sciences | 179.53 Bn | 176.35 Bn | 6.22 Bn | -10.18 |
| 3 | Vertex Pharmaceuticals | 131.25 Bn | 123.40 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.56 Bn | 73.57 Bn | 3.93 Bn | 13.40 |
| 5 | Argenx Se | 60.76 Bn | 55.57 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.69 Bn | 48.55 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.10 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.79 Bn | 30.51 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.12 Bn | 29.12 Bn | 1.16 Mn | - |
| 10 | GT Biopharma | 7.28 Mn | 7.28 Mn | - | - |